Advertisement
Monday, Aug 08, 2022
Outlook.com
Outlook.com

MedPlus IPO Opens Today: Know What Brokerage Houses Say Before You Subscribe

MedPlus IPO’s price band has been fixed at Rs 780 to Rs 796 per equity share and India's second-largest pharmacy retailer firm aims to raise Rs 1,398.30 crore from this issue.

MedPlus IPO Opens Today: Know What Brokerage Houses Say Before You Subscribe
MedPlus IPO Opens Today: Know What Brokerage Houses Say Before You Subscribe
outlookindia.com
2021-12-13T09:13:09+05:30

The initial public offering (IPO) of MedPlus Health Services Limited is opening on Monday and it will remain available for bidding till 15th December 2021.

The price band of the book built issue has been fixed at Rs 780 to Rs 796 per equity share and India's second-largest pharmacy retailer company aims to raise Rs 1,398.30 crore from this public offer ( Rs 600 crore from fresh issue and Rs 798.30 crore through Offer for Sale or OFS).

Proceeds of the fresh issue will be used for funding the working capital requirements of the company's subsidiary, Optival.

Half of the issue size has been reserved for qualified institutional buyers (QIBs), 15 per cent for non-institutional investors and 35 per cent for retail investors.

Investors can bid for a minimum of 18 equity shares and in multiples thereof.

According to market observers, shares of Medplus Health Services are available at a premium of Rs 280 in the grey market today.

Check out what brokerage houses/analysts say about the IPO, as per Moneycontrol report.

Aditya Birla Capital

At the issue price, Medplus will trade at 3.1x FY21 P/S and 40x FY21 EV/EBITDA. Additionally, given the blue ocean opportunity in Medplus’ business verticals and the gradual shift from unorganised to organised sector, in the near term, Medplus would be valued more on its longer-term growth potential and less on current financials.

Prabhudas Liladhar

The brokerage house  identifies the key risks of increase in competitive intensity from online players and delay in EBITDA break-even at new stores. Medplus is a compelling play in growing the omni-channel model.

It assigns a ‘subscribe’ rating to the issue as it believes that Medplus will gain scale and profitability.

Given its fully integrated offerings, the company is profitable, despite higher discounts across omni-channel deliveries. At the upper end of band, Medplus will trade at 2.4x EV/sales and 44x EV/EBITDA (adjusted for pre-IND AS) on annualising H1FY22 numbers.

KR Choksey

Given that the company has a very strong asset turnover with an eye on improving its profitability further and that the IPO valuation appears cheaper, compared to its peers set, the brokerage house recommend subscribing to the IPO.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

In happy times and sad, Habba Khatun’s sensuous songs make both young and old emotional. With the never-ending conflict bringing tragedies to every doorstep, Habba’s lyrics of separation amplify their mourning.

How Indian Laws Govern People’s Right To Love And Live

How Indian Laws Govern People’s Right To Love And Live

In India, only those relationships between a man and a woman are considered to be legitimate when there is a marriage between the two.

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Virat Kohli, 33, had recently stepped down as India's T20I captain and was subsequently removed as the ODI captain.

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

A Mahila Congress leader, who is the face of the ‘Ladki Hoon, Lad Sakti Hoon’ campaign, however, has accused the party of anti-women bias after she was denied a ticket.

Advertisement